New Centre of Excellence at Electronic City campus to offer specialised care in epilepsy, cerebrovascular disorders, neurointervention, skull base and spine surgery
The newly established institute is equipped with advanced infrastructure designed to integrate multiple specialties under one roof
Alto met its enrollment goal with 83 patients across 13 US clinical sites
Immunology remained AbbVie’s largest and fastest-growing segment, delivering $30.41 billion in global net revenues,
ALTO-207 combines pramipexole, a dopamine D3-preferring D3/D2 agonist approved for Parkinson’s disease
The centre is equipped with the most modern tools and provides an environment soothing for all professionals and patients
Base4's drug discovery platform allows its collaborators to evaluate billions of novel small molecules to identify and progress RNA-modulators for important diseases
KBR will provide outreach, education and data analytics to support critical neuroscience research for the prevention and treatment of military members with CTE
Mindset disagrees with and denies the allegations set forth from Reunion.
Subscribe To Our Newsletter & Stay Updated
